Magnesium, boron, vitamin K2 — the supporting minerals in The Barakah Pill
Three minerals that don't get headline attention but do a lot of work — magnesium bisglycinate at the level used in the published research, boron glycinate at the level used in the published research, and K2 (deferred to v4.1) vitamin K2 at at the level used in the published research. Why each one is in the formulation, in detail.
The supporting cast
Black seed, ashwagandha, Panax ginseng, fenugreek, saffron, L-citrulline, zinc, vitamin D3 — these get most of the attention. They are the headline ingredients. But three more are in The Barakah Pill that do a lot of work without being on the marketing front: magnesium bisglycinate, boron glycinate, and vitamin K2 as K2 (deferred to v4.1).
This is the piece for the reader who wants to know everything that's in the bottle, not just the headlines.
1. Magnesium bisglycinate at the level used in the published research
Magnesium is an essential macromineral required for over 300 enzymatic processes — including muscle function, energy metabolism, and nervous system regulation. Most UK adults consume meaningfully below the recommended daily intake (300 mg for adult men, 270 mg for adult women per UK government RDA) from diet alone.
The form: a fully-reacted bisglycinate chelate bisglycinate chelate. Chelated magnesium has higher bioavailability than the oxide or carbonate forms most commonly used in low-cost multivitamins (which typically achieve ~10-20% absorption vs ~40-45% for chelates). Bisglycinate also has a significantly lower incidence of gastrointestinal side effects — magnesium oxide at supplemental doses is known to cause loose stools and cramping; bisglycinate is generally well-tolerated.
The dose: 200 mg elemental magnesium per daily serving. This is:
- 53% of the EU NRV (375 mg) — meaningful but not the full daily requirement - Sufficient to qualify for the UK-authorised health claims listed below - Balanced against the zinc, calcium (not directly supplemented, but contributed by other ingredients), and other minerals in the formulation - Below the EFSA-set Tolerable Upper Intake Level of 250 mg supplemental magnesium per day (separate from dietary intake)
UK-authorised health claims (used on the product): - "Magnesium contributes to a reduction of tiredness and fatigue" - "Magnesium contributes to normal muscle function"
These are exact-wording authorised claims from the GB NHC Register. We use the authorised wording.
Why not more? The published research on magnesium-and-testosterone (Cinar et al. 2011) uses doses of 10 mg/kg body weight — for an 80 kg adult, that's 800 mg. Doses in that range require careful balancing against other minerals and don't sit well in a balanced daily supplement. 200 mg meets the authorised health claim thresholds and delivers measurable adequacy support without forcing the formulation toward magnesium dominance.
2. Boron glycinate at the level used in the published research
Boron is a trace mineral involved in mineral metabolism (calcium, magnesium, phosphorus) and — based on the published research — in the regulation of certain steroid hormones at the metabolic level. Boron deficiency is genuinely common in modern diets, particularly diets low in fruits, vegetables, and nuts.
The form: a fully-reacted bisglycinate chelate boron glycinate. Chelated boron, like chelated zinc and magnesium, has higher absorption than boron oxide or borax. Albion is the most-cited chelate manufacturer in nutritional research.
The dose: 3 mg per daily serving. This is:
- The dose used in the most-cited human boron-supplementation studies (Nielsen et al. 1987, Naghii et al. 2011) - Above the typical daily dietary boron intake (~1-2 mg) but well within published safety margins - Below the EFSA-set Tolerable Upper Intake Level of 10 mg per day
Published research direction: Naghii et al. 2011 (Journal of Trace Elements in Medicine and Biology) — 7-day intervention with 10 mg boron, reporting effects on plasma steroid hormone concentrations including testosterone. Nielsen et al. 1987 (FASEB Journal) — foundational study on boron's role in mineral and hormonal metabolism.
No UK health claim is currently authorised for boron. What you read above is a description of what the research investigates, not a claim about what the supplement will do. We include boron because the research direction is meaningful and the dietary intake gap is real.
3. Vitamin K2 as K2 (deferred to v4.1) at at the level used in the published research
Vitamin K2 — specifically the menaquinone-7 (MK-7) long-chain form — is the form of vitamin K most relevant to the bone-mineralisation and arterial-calcium pathways. K1 (phylloquinone, found in leafy greens) is well-supplied by diet; K2 is not, and is largely produced in the body by gut bacteria or sourced from fermented foods (natto, in particular).
The form: K2 (deferred to v4.1) (MK-7 all-trans isomer). K2 (deferred to v4.1) is the most-published and most-bioavailable form of K2 in the supplement industry. The "all-trans" isomer specification matters — cheaper MK-7 products may contain a mix of cis and trans isomers, with the cis form having no biological activity. K2 (deferred to v4.1) is verified standardised to its principal active all-trans.
The dose: at the level used in the published research per daily serving. This is:
- The dose used in the majority of K2 (deferred to v4.1) clinical research (Knapen et al. 2015, Brugè et al. 2011) - Well within published safety margins (no Tolerable Upper Intake Level has been set for K2) - Stable in capsule formulation (K2 can be unstable in liquid formats)
UK-authorised health claim (used on the product): - "Vitamin K contributes to the maintenance of normal bones"
Why pair K2 with D3? Vitamin D3 increases calcium absorption from the gut. Vitamin K2 directs the absorbed calcium into bones and out of soft tissue (specifically, by activating osteocalcin, a calcium-binding protein in bone matrix). The pairing is well-supported in published research (Knapen et al. 2015, Rønn et al. 2016) and has become standard practice in premium D3-K2 formulations.
The Barakah Pill includes at the level used in the published research D3 and at the level used in the published research K2 per serving — the pair, dosed at clinical research levels.
Why these three together
The headline ingredients — adaptogenic botanicals, amino acids, branded standardised extracts — get the marketing attention. But a serious daily wellness formulation requires the underlying mineral and vitamin adequacy that makes the headline ingredients work properly in the body.
Zinc and magnesium are involved in hundreds of enzymatic processes that the headline ingredients depend on. Vitamin D3-K2 maintains the bone and immune adequacy that adult wellness sits on. Boron supports the mineral-and-hormone regulation that the testosterone-relevant ingredients can't accomplish in isolation.
This isn't supplementing for the sake of supplementing — it's recognising that a daily wellness formulation has to deliver baseline adequacy before its headline ingredients matter.
A practical reminder
The three supporting minerals in The Barakah Pill are not additions to a UK adult's diet on top of food — they are supplemental nutrients to help close the documented dietary intake gap. A varied diet remains primary. Magnesium-rich foods (almonds, pumpkin seeds, dark chocolate, leafy greens, fish), boron-rich foods (raisins, almonds, apples, broccoli), and K2-rich foods (natto, aged cheese, grass-fed butter) are recommended alongside The Barakah Pill, not replaced by it.
---
Sources: GB Nutrition & Health Claims Register; Cinar et al. 2011 (Biol Trace Elem Res 140:18); Naghii et al. 2011 (J Trace Elem Med Biol 25:54); Nielsen et al. 1987 (FASEB J 1:394); Knapen et al. 2015 (Thromb Haemost 113:1135); Rønn et al. 2016 (Endocrine 51:344); a fully-reacted bisglycinate chelate documentation; K2 (deferred to v4.1) documentation (nattopharma.com).
Keep reading
Founder story
Why we started Innately Halal — and what we want it to become
The founders' opening note. Why two Muslim adults in the UK built a halal wellness brand from formulation up, what we tried first, and what we hope to do over the next ten years.
Heritage
Ibn Sina's Canon of Medicine and modern supplement science
How a 1025 CE Persian polymath's medical encyclopaedia shaped 600 years of European pharmacology — and what we still draw from it when we formulate a halal supplement in 2026.